唐氏综合征患儿Fontan术后死亡率显著改善
基于STS先天性心脏病数据库的16年回顾性研究(2001-2016,共12,074例)显示,Fontan手术总体院内死亡率从2.4%降至1.3%(P<.001)。唐氏综合征组院内死亡率仍显著高于非唐氏组(12.3% vs 1.6%,P<.001),多变量分析中唐氏综合征是院内死亡的最强预测因子(OR 11.6,95%CI 5.1-26.4)。
要点
- Fontan术后总体院内死亡率近期显著改善至1.3%
- 唐氏综合征组院内死亡率12.3%,仍显著高于非唐氏组1.6%
- 唐氏综合征是院内死亡最强预测因子,校正OR 11.6
核心结论
- 当代Fontan手术院内死亡率显著改善,但唐氏综合征仍是院内死亡和并发症的重要危险因素。
研究设计与样本
- 回顾性研究,使用STS先天性心脏病数据库,纳入2001-2016年接受Fontan手术的功能性单心室患者共12,074例(唐氏81例,非唐氏11,993例)。
- 主要结局为院内死亡率,采用单变量和多变量logistic回归分析预测因素。
主要发现
- 总体院内死亡率在近期(2009-2016)显著改善:2.4%至1.3%,P<.001。
- 唐氏组院内死亡率高于非唐氏组(12.3% vs 1.6%,P<.001),OR 8.6(95%CI 4.4-17.0)。
- 唐氏组30天死亡率更高、术后中位住院时间更长、术后并发症发生率更高。
- 多变量模型显示唐氏综合征是院内死亡最强预测因子,OR 11.6(95%CI 5.1-26.4),校正时代效应、体重和主要心脏诊断等变量。
临床怎么用
- 唐氏综合征患儿行Fontan手术前应充分评估死亡风险,术后加强监护和并发症管理。
- 近期Fontan手术整体预后改善,但唐氏综合征仍是高风险人群,需个体化决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Down syndrome (DS) is considered a risk factor for mortality associated with the Fontan operation. The objective was to show the contemporary short-term outcome of the Fontan operation for a functionally univentricular heart in patients with DS and non-DS, along with an analysis of significant predictors for in-hospital mortality. METHODS: This was a retrospective study using The Society of Thoracic Surgeons Congenital Database to assess in-hospital mortality and its predictors in patients with DS and non-DS undergoing the Fontan operation over 16 years (2001-2016). The primary outcome was in-hospital mortality. Statistical analysis was performed using univariable and multivariable logistic regression models. RESULTS: Our study cohort consisted of 12,074 patients (81 DS and 11,993 non-DS). The overall in-hospital mortality rate significantly improved in the recent era (2009-2016): 2.4% to 1.3%, P < .001. The DS group had a higher in-hospital mortality rate (12.3% vs 1.6%, P < .001) with an odds ratio of 8.6 (95% confidence interval, 4.4-17.0). The DS group had a higher 30-day mortality rate, a longer median postoperative length of stay, and a higher incidence of postoperative complications. The multivariable model showed that DS was the strongest predictor of in-hospital mortality, with an odds ratio of 11.6 (95% confidence interval, 5.1-26.4), adjusted for other significant variables including era effect, weight, and primary cardiac diagnosis. CONCLUSIONS: The in-hospital mortality for the Fontan operation significantly improved in the contemporary era. DS was a significant risk factor for in-hospital morbidity and mortality associated with the Fontan operation.
引用
- Sarno LA, Walters HL, Bondarenko I, et al. Significant Improvements in Mortality After the Fontan Operation in Children With Down Syndrome. Ann Thorac Surg. 2019. PMID: 31525348. doi:10.1016/j.athoracsur.2019.07.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。